Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
Entresto was the company's top-selling product in 2023, generating sales of around $6B. MSN had been aiming to launch its ...
The case revolves around Novartis' contention that MSN's generic contains small amounts of crystalline forms of the active ingredients in Entresto that would infringe a patent on the drug (No ...
The U.S. Court of Appeals has reportedly ruled against Novartis (NYSE:NVS) in its bid to prevent the U.S. launch of a generic ...
A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...
Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...
When pregnancy is detected, consider alternatives and discontinue Entresto. However, if there is no appropriate alternative therapy with drugs affecting the renin-angiotensin system, and if the ...
A generic contains an exact copy of the ... asked questions about Verquvo’s cost. Verquvo and Entresto are both prescription drugs used to help prevent complications of heart failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results